Love him or hate him, Martin Shkreli, aka Pharma Bro, is calling for shorts on Bitcoin ($BTC), MicroStrategy (MSTR), and a crop of quantum computing stocks.
Some say Martin is desperate for attention (again) and he posts opinions that go against the grain, so people talk about him. Now a financial podcaster, that gamble could strengthen his talent for reading the markets or leave him scrambling to explain a high-profile failure.
Bitcoin is down 5.4% in the last day since the call and MicroStrategy is down 6.63% in the same period.
Martin Shkreli: public enemy number one
Martin Shkreli became public enemy number one in 2015 after raising the price of a life-saving drug by 5,000%, securing his place as Big Pharma’s smug poster boy and earning the nickname ” Pharma Bro.”
Two years later, the rise ended in a crash: securities fraud charges landed him a four-year prison sentence. Since his release, Shkreli’s aura has not faded. Even his fiercest detractors admit that he has an uncanny gift for reading the financial pulse.
Shkreli’s latest podcast took a scalpel to the year’s flashiest artists. Bitcoin, MicroStrategy, and quantum computing stars like IonQ (IONQ) and Quantum Computing Inc (QUBT) were all on its shortlist. Stocks could well peak with massive gains in 2024, but Shkreli is betting the decline is near.
And, true to form, he reserved some harsh criticism for Michael Saylor, the Bitcoin-loving face of MicroStrategy.
“Michael Saylor is crazy. His Bitcoin bet will hurt MicroStrategy in the long run,” Shkreli said during a podcast episode.
Shkreli doubled down on his position while admitting that shorting MicroStrategy has been a painful position due to its stock’s stellar performance this year.
Why go against the market and MicroStrategy?
Shkreli’s bearish outlook may seem out of sync with many investors’ optimism toward Bitcoin and tech stocks, but he backs his position with market observations. Underscoring the unusual state of the stock market, Shkreli highlighted recent signs of a potential reversal in momentum:
- The Dow Jones has just ended its worst losing streak since 1978: nine consecutive days in the red.
- Meanwhile, the S&P 500’s price-to-book ratio is heading toward dot-com bubble territory, setting off alarm bells.
- If that wasn’t enough, the SPY ETF has seen 11 straight days of falling rather than rising stocks, a grim trend last seen in 2001.
Shkreli believes these moves suggest complacency and overvaluation in the market, creating opportunities for contrarian investors.
Bitcoin, which has reached new highs in 2024, now finds itself at the center of Shkreli’s short selling strategy. According to Shkreli, historical trends suggest an imminent withdrawal of the cryptocurrency. Although he did not provide a specific price target, his critical stance aligns with concerns about Bitcoin’s valuation following its meteoric rise.
“Bitcoin grew too fast, too soon. A significant correction seems inevitable,” Shkreli hinted during a recent discussion.
Is Shkreli right this time?
Although Shkreli’s moral compass and his past actions have been widely criticized, his ability to spot changes in market dynamics is hard to ignore.
Of course, contrarian strategies are risky. Many of the assets Shkreli recommends shorting have demonstrated strong fundamentals or growing investor interest. For example, quantum computing stocks like IonQ are gaining traction through technological breakthroughs and partnerships. Bitcoin also continues to enjoy widespread adoption and institutional investment.
While Shkreli’s ideas are worth considering, investors should proceed with caution, especially in today’s unpredictable climate.
EXPLORE: 11 Best AI Crypto Coins to Invest in 2024
Join the 99Bitcoins News Discord here for the latest market updates
The post Martin Shkreli Loads MicroStrategy Shorts: Will Pharma Bro Beat Saylor? appeared first on 99Bitcoins.
